Prions are unusual infectious pathogens causing scrapie of sheep and goats as well as Creutzfeldt-Jakob disease of humans. Biochemical and genetic studies contend that the scrapie isoform of the prion protein (PrPs) is a major component of the prion. Limited proteinase K digestion of
Scrapie is a degenerative neurological disease of sheep and goats that can be transmitted to laboratory rodents. Much evidence argues that the infectious agent is not a virus, but rather an unprecedented particle, a prion (1) . The only macromolecule in preparations highly enriched for prion infectivity identified to date is a protein of 33-35 kDa, designated the scrapie isoform of the prion protein (PrPSC) (2) . Removal of the N-terminal 67 amino acids of hamster PrPSC by limited proteinase K digestion yields a prion protein (PrP) of [27] [28] [29] [30] kDa that is designated (3) . Many biochemical (4-9), genetic (6, 10, 11), biophysical (12), neuropathologic (13) (14) (15) (16) , and cell biological (17) lines of evidence support the idea that PrPSC is a component of the infectious particle. For several years, the only highly purified preparations of scrapie prions were in the form of rod-shaped amyloid polymers (4) (5) (6) . Recently, we have developed a protocol to disperse these rod-shaped polymers into detergent-lipidprotein complexes (DLPC) and liposomes with full retention of infectivity (12) . This protocol was subsequently adapted for DLPC formation directly from brain microsomes, and it avoids the aggregation of PrPSC (18) .
We reasoned that PrP monoclonal antibody (mAb)-affinity chromatography would copurify solubilized PrPSC and prion infectivity ifPrPSC were a component ofthe infectious scrapie particle. On the other hand, this procedure should separate PrPSc from infectivity if the two were unrelated, as suggested by some investigators (19) (20) (21) . As reported here, fractions eluted from the immunoaffinity column at alkaline pH contained one protein, PrPsc, and high titers of scrapie infectivity. We also demonstrate that rabbit polyclonal PrP 27-30 antiserum (a-PrP 27-30) can neutralize scrapie infectivity. (25) . NaDodSO4/PAGE was done according to the method of Laemmli (26) . Immunologic blots (27) and silver staining ofgels (28) were done as described previously with 0.01% NaDodSO4 in the electrotransfer buffer (17) . Concentration of PrP was estimated visually by comparing the volume ofa given fraction required for detection on an immunologic blot as well as the intensity of staining with that of standards.
MATERIALS AND METHODS
Preparation of Immunoaffinit Resin. PrP mAb 13A5 was purified by a Protein A-Sepharose CL-4B column in the presence of 0.5 M NaCl at pH 8.5; =10 mg of antibody was obtained from 1 liter of hybridoma medium (29) . The PrP mAbs (10 mg) were crosslinked to Protein A-Sepharose CL-4B (4 ml) using 20 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. stored at 40C in a suspension containing 0.02% sodium azide. Alternatively, the IgG fraction from a polyclonal rabbit a-PrP 27-30 (RO17) (17) or a polyclonal rabbit human immunodeficiency virus (HIV)-gpl20 synthetic peptide antiserum was crosslinked to Protein A-Sepharose CL-4B. This a-PrP 27-30 was raised against the prion rods that had been denatured in 0.5% NaDodSO4 and boiled for 5 min. The synthetic peptide antiserum was raised against the amino acids 465-480 of the HIV-gpl2O (CFRPGGGDMRDNWRSEL) and was provided by T. Krowka. Purification of Brain Microsomes. Scrapie-infected hamster brains were homogenized with a Polytron for 10 sec in 320 mM sucrose to produce a 1o (wt/vol) homogenate. All procedures were performed at 4°C unless otherwise stated. After centrifugation at 5000 x g for 10 min, the pellet was discarded, and the supernatant was centrifuged for 1 hr at 100,000 x g. The resulting pellet was resuspended in a minimal volume of a buffer containing 10 mM Tris HCl, pH 7.4/150 mM NaCl and then subjected to osmotic shock by a 100-fold dilution into 10 mM Tris-HCl, pH 7.4/2 mM phenylmethylsulfonyl fluoride. After 20 min the suspension was centrifuged for 1 hr at 100,000 x g, and the osmotic-shock step was repeated. The purified microsomal membranes were resuspended at a protein concentration of 5 mg/ml and either used immediately or stored at -70°C.
Preparation of DLPC. Ten milliliters of microsomes purified from scrapie-infected brains were added to a glass test tube containing 100 mg of dry PtdCho and mixed in a Vortex before the addition of Sarkosyl to a final concentration of 2% (wt/vol) (12, 18) . The mixture was then sonicated for 10 min in a cylindrical bath sonicator and centrifuged at 100,000 x g for 1 hr. The supernatant fraction contained DLPC, which were used for further purification. RESULTS A microsomal membrane fraction was prepared from scrapieinfected brains containing 50% of the scrapie infectivity and 50% of the PrP (Table 1) . The microsomes were solubilized by a combination of Sarkosyl (2% wt/vol) and PtdCho (5 mg/ml). The DLPC formed by this procedure were subjected to ultracentrifugation, and the supernatant was applied to PrP mAb-affinity matrix. mAbs raised against PrP 27-30 were crosslinked to Protein A-Sepharose to minimize the leakage of the antibodies. After overnight incubation at 4°C, the immunoaffinity matrix was washed with buffers containing various increased concentrations of salt and different detergent as well as 2% (wt/vol) PtdCho. The PtdCho was included to prevent aggregation of NPSC while bound to the matrix and during elution.
Elution of PrP from the matrix was accomplished with higher and higher concentrations of alkali; the pH of the eluant was increased progressively from 9.5 to 11.2. At pH 9.5, the first detectable PrP was eluted. Acid was also examined, but it was not efficient in eluting the PrP. Because alkali is known to inactivate scrapie infectivity (31), samples were titrated immediately after elution to pH 7.
Selected fractions of the immunoaffinity purification procedure were analyzed by NaDodSO4/PAGE as shown in Fig.  1 . Most unbound PrP was eluted in the void volume; that not all of the PrP molecules are bound to the matrix may result from some PrP molecules possessing a configuration unfavorable for binding. No PrP was detected in subsequent washes before increasing the pH of the eluant buffer to 9.5 as judged by immunologic blotting (Fig. 1 Upper) . Approximately 9% of the PrP was recovered in the alkaline eluate; this represents =20%o of the PrP in the microsome fraction. An equal amount of PrP was found in the flow-through fraction. At least 20% of the unaccounted-for PrP remained bound to the column and was eluted by additional washes with the pH 11.2 buffer. The extent of PrP purification was *5700-fold, and the purity of the PrP, as judged by NaDodSO4/PAGE with silver staining, was excellent (Fig. 1 Lower). Similar results were obtained when the IgG fraction of a polyclonal rabbit a-PrP 27-30 was coupled to Protein ASepharose and used in place of the PrP mAb columns.
Aliquots eluted from the immunoaffinity column at alkaline pH were examined by electron microscopy after negative staining with uranyl formate. Amorphous vesicles but no prion rods were seen (data not shown).
Some prion proteins in purified fractions are probably the cellular isoform of the prion protein because all of our PrP mAbs to date bind to both PrP isoforms. To estimate the amount of PrPSC in the purified fractions, we digested the fractions with proteinase K, which catalyzes the hydrolysis of the cellular isoform of PrP and the conversion of PrPSc to PrP 27-30. As depicted in Fig. 1 (lane 10) , the majority of the purified PrPSc is converted to PrP 27-30 as evidenced by the intensity of immunostaining as well as silver staining on NaDodSO4/PAGE. From these digestions, we conclude that most of the PrP in our purified fractions is PrPSc.
Aliquots of fractions from the PrP immunoaffinity column were inoculated into hamsters for bioassay of scrapie prion titer. Those fractions, which contain PrPSC, also contain scrapie infectivity, whereas those fractions with no detectable PrPSc contain either low levels of scrapie prions or none (Table 1) . Moreover, the amount of PrPSc recovered from the column was a function of the eluate pH and was roughly proportional to the prion titer. Although the specific infectivity (ID50 units per mg of protein) increased by 4000-fold during purification, the ID50 units per ,ug of PrP remained constant. We recovered -4% ofthe total infectivity in the pH 11.2 eluate; this amount corresponds to l40% of infectivity found in the microsome fraction (Table 1 ). An additional 10%o of the microsome infectivity was found in the flow-Proc. Natl. Acad. Sci. USA 85 (1988) purification and the recovery for any particular step. Even though the prion titers given in Table 1 represent the means from three separate experiments, it may be more prudent to claim a 103-to 104-fold purification of scrapie infectivity than the =4000-fold claimed, as described above.
To establish the specificity of our immunoaffinity purification protocol, we constructed an immunoaffinity matrix using an unrelated antibody raised against a synthetic peptide of glycoprotein 120 of HIV. The results of the chromatography are depicted in Fig. 2 . No PrPSC was eluted from the column regardless of the buffer pH, establishing that the binding of the PrPSC to the column was specific. Aliquots of the fractions from this experiment were bioassayed in hamsters. Prion infectivity was recovered only in the flowthrough fractions; none was found in fractions eluted with alkali (Table 2 ). Comparing the recoveries of prion infectivity eluted by alkali for the two columns reveals an impressive difference of =10' (Tables 1 and 2 ).
Concurrent with the development of an immunoaffinity purification protocol, we examined the immunoprecipitation of purified PrP 27-30 rods dispersed into DLPC. Polyclonal rabbit PrP 27-30 antiserum (RO18) precipitated o50% of the radioiodinated PrP 27-30 in DLPC in the presence of Protein A-Sepharose (Table 3) . Preimmune serum precipitated 1-2% of the PrP 27-30. PrP mAb 13A5 could not precipitate a significant portion of the PrP 27-30 in the presence of Protein A-Sepharose; presumably, this was due to the relatively poor Microsomes isolated from 15 scrapie-infected hamster brains were solubilized by a combination of Sarkosyl and PtdCho. The resulting DLPC were incubated with constant mixing by using a rocking platform overnight at 4TC in the presence ofthe immunoaffinity resin. The resin was then loaded into a column and washed sequentially with the three buffers described in Fig. 1 . Immunologic blot of a NaDodSO4/PAGE of selected fractions stained with rabbit a-PrP 27-30 (R018). Lanes: 1, DLPC; 2, flow-through fraction; 3, third wash; 4, fifth wash; 5, seventh wash; 6, pH 10 eluate; 7, pH 11.2 eluate. M, of protein standards are given in kDa.
Biochemistry: Gabizon et al. binding of murine IgG molecules to Protein A. The efficacy ofPrP mAb immunoprecipitation was substantially increased by using rabbit antiserum (RO21) raised against PrP mAb 13A5, as a second antibody (a-PrP mAb 13A5) to facilitate binding to Protein A-Sepharose (Table 3) . With all PrP antibodies tested, high concentrations were necessary to obtain maximal immunoprecipitation of 125I-labeled PrP 27-30 in DLPC.
Immunoprecipitated fractions were also assessed for scrapie infectivity (Table 3 ). The prion titers of samples treated with rabbit a-PrP 27-30 were reduced by a factor of 100, whereas exposure to preimmune serum did not alter the titer (Table 3) . In contrast to the polyclonal rabbit a-PrP (RO18), PrP mAb 13A5 as well as polyclonal rabbit a-PrP mAb 13A5 (2021) failed to neutralize scrapie infectivity associated with the DLPC.
To extend our finding that a-PrP 27-30 can neutralize scrapie infectivity, we incubated PrP 27-30 DLPC with various concentrations of antiserum. Preimmune serum failed to alter prion titer, whereas immune serum caused a progressive decrease in titer (Fig. 3) . A correlation between the ratio of a-PrP 27-30 to PrP 27-30 and diminishing infectivity was found (Fig. 3) . DISCUSSION The immunoaffinity purification and neutralization studies reported here provide direct immunological and chromatographic demonstrations of a link between PrPSc and prion infectivity. For many years, investigators searched for a detergent that would solubilize scrapie prion infectivity (32, 33) . Attempts at purification, as well as characterization of the scrapie agent, were plagued by the smearing of scrapie infectivity across centrifugation gradients, electrophoretic fractions, and chromatography profiles (34, 35) . The experimental protocols described here could not have been done without functional solubilization of scrapie prions into DLPC (12, 18) . Our results combined with other immunologic, biochemical, and genetic data make it difficult to contend that PrPSc is not a component of the infectious particle but rather a pathologic product of scrapie infection.
Attempts to neutralize scrapie infectivity in fractions containing prion amyloid rods were unsuccessful (36) . Only after the rods were dispersed into DLPC was a reduction of scrapie infectivity found with PrP antibodies (Fig. 3 and Table 3 ). Presumably, the DLPC expose epitopes that allow neutralizing antibodies to bind; these same epitopes in rods may be buried and inaccessible to antibodies. Neutralization of viruses by antibodies has been widely studied and is thought to be a complex process (37) . Antibodies have also been used to assign a biological activity to a specific protein using neutralization or immunoprecipitation procedures (38) (39) (40) ). The precise mechanism by which antibodies raised against NaDodSO4/PAGE-purified PrP 27-30 reduce scrapie infectivity remains to be established.
In part, the need for high concentrations of PrP antiserum to demonstrate neutralization may be due to the high particleto-infectivity ratio. We estimate that the ratio of PrPSc molecules per ID50 unit in our immunoaffinity-purified fractions is 105. This particle-to-infectivity ratio resembles that previously reported for the prion amyloid rods, where it ranges from 104 to 106 (4, 5).
The experimental results of the complementary immunologic approaches reported here combined with results of biochemical and genetic studies mount a convincing argument for PrPSC being a major component of the infectious scrapie prion. This is an important feature, distinguishing prions from viruses, because PrP is encoded by a host gene and not by a nucleic acid within the prion particle. Our results argue neither for nor against a second molecule within the prion-such as a small nucleic acid; however, all attempts to demonstrate a scrapie-specific polynucleotide have been unsuccessful to date. The development of an immunoaffinity purification protocol and procedures for chromatography will undoubtedly facilitate structural studies of prions as well as experiments focusing on how prions multiply.
